HOME >> BIOLOGY >> NEWS
Protective gene may enhance vaccine responses

Researchers from the University of Chicago have discovered the first of a new class of "protective factors" that appear to be required for the development of memory T cells, the cells that form the core of a vaccine response. The finding could help scientists create more effective vaccines and may lead to potent immune system-based therapies against diseases that have previously eluded vaccines, such as cancer or AIDS.

When the immune system detects an invader, such as a virus, T cells with an affinity for that particular invader multiply rapidly, attack and eliminate infected cells. Once the infection is cleared, however, 90 to 95 percent of those T cells die off, a process called contraction. The five percent or so that survive are known as memory T cells. If a similar infection recurs, these experienced warriors are prepared to rush to the site, recognize that invader and eradicate it again.

Scientists know a great deal about the rapid proliferation and differentiation of these T cells but very little about the factors that regulate contraction. In the September, 2004, issue of Nature Immunology published on-line August 15 -- the researchers show that activation of the gene for the Serine protease inhibitor 2A (Spi2A) can prevent the death of T cells during the contraction phase, resulting in about five times as many memory T cells.

"Drugs based on protective factors such as Spi2A could provide an enormous boost to vaccines," said study author Philip Ashton-Rickardt, professor of pathology and a member of the committee on immunology at the University of Chicago. "This could allow us to extend the duration of an immune response against chronic infections or to focus the power of the immune system on tumor cells, targets that have thus far been quite elusive."

The researchers began by screening approximately 11,000 genes from mouse T cells, to find the small number of genes that were more active in the T cells that survived th
'"/>

Contact: John Easton
jeaston@uchospitals.edu
773-702-6241
University of Chicago Medical Center
15-Aug-2004


Page: 1 2

Related biology news :

1. Protective mechanism exploited by tumors may provide new cancer treatment
2. Protective protein caps discovered at ends of human chromosomes
3. Experimental Staph Vaccine Broadly Protective In Animal Studies
4. Potential for enhanced sequestration of carbon in soils supports evaluations
5. Probing the surface of white blood cells to enhance immune system medicine
6. Plant gene discovery could enhance plant growth, reduce fertilizer needs and phosphate pollution
7. Technology could enhance accuracy of breast biopsy
8. Manipulating biotope space can enhance beneficial biodiversity effects
9. Taxanes may enhance immunity in breast cancer patients
10. UC Riverside researchers develop low-carb corn with enhanced protein and oil
11. Athletics, genetic enhancement and ethics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2019)... ... August 19, 2019 , ... Since ... use of ultra-thin two dimensional slices which are placed on microscope slides, stained ... complex tissues and complicated features such as vasculature and thus researchers in the ...
(Date:8/15/2019)... ... ... Deep Science Ventures (DSV), a new paradigm for applied science, today announced ... 100 companies over the next 10 years to address the urgent need for new ... was founded to create a better method for launching science companies; one that takes ...
(Date:8/15/2019)... ... , ... Serialization deadlines in the US and European Union ... becomes fully applied in the United States in 2023, pharmaceutical companies are scrutinizing ... most regulations?including the Drug Supply Chain Security Act (DSCSA)?have required minimal system capabilities. ...
Breaking Biology News(10 mins):
(Date:8/15/2019)... ... August 15, 2019 , ... PathSensors announced today that Roger ... of the Institute of Food Technologists (IFT) Board of Directors, Illinois Institute of ... for Food Safety and Applied Nutrition (JIFSAN) Advisory Council and the University of ...
(Date:8/14/2019)... STATE COLLEGE, Pa. (PRWEB) , ... August 13, ... ... leader in nuclear receptor and in vitro toxicology testing solutions, announced the appointment ... of healthcare industry experience to the Board. , Mark McLoughlin will lend his ...
(Date:8/14/2019)... ... August 13, 2019 , ... ... prepackaged mobile phases for QC laboratories. After gaining a few significant clients, Lifecycle ... approach into a valued supplier of manufacturing processing solutions, including reagents for tissue ...
(Date:8/8/2019)... , ... August 08, 2019 , ... ... Agents for sales and service organizations, today announced that the company’s Studio ... Award for the IVA market . Inference will officially accept the award at ...
Breaking Biology Technology:
Cached News: